Literature DB >> 3141291

The aetiology of acute hepatitis in Taiwan: acute hepatitis superimposed on HBsAg carrier state as the main aetiology of acute hepatitis in areas with high HBsAg carrier rate.

C M Chu1, I S Sheen, Y F Liaw.   

Abstract

The aetiology of sporadic acute hepatitis in Taiwan was studied in a consecutive series of 273 patients, 209 males and 64 females, aged from less than 1 to 73 years. Only eight patients (2.9%) had acute hepatitis A, 36 (13.2%) acute hepatitis B and 57 (20.9%) had acute non-A, non-B hepatitis (NANB). The remaining 172 patients (63.0%) were HBsAg positive but anti-HBc IgM negative and were classified as acute hepatitis in chronic HBsAg carriers. Age-specific analysis revealed that acute hepatitis types A and B accounted for 35% and 47%, respectively of acute hepatitis in patients below age 10, but their prevalence decreased dramatically with increasing age and remained quite low in patients over age 40. In contrast, acute hepatitis NANB occurred predominantly in the older patients. The prevalence of acute hepatitis NANB was 11 to 15% in patients below age 40, but increased gradually with increasing age thereafter. Of the patients over age 60, 58% had acute hepatitis NANB. Acute hepatitis in chronic HBsAg carriers accounted for 59 to 76% of acute hepatitis episodes in patients over age 10 and below age 60. Sex-specific analysis revealed that the prevalence of acute hepatitis A or B showed no significant sex difference, whereas acute hepatitis in chronic HBsAg carriers occurred predominantly in males and acute hepatitis NANB occurred predominantly in females. Of the acute hepatitis episodes in chronic HBsAg carriers about one-third was due to hepatitis Delta virus superinfection, while the remaining two-thirds were most likely acute exacerbations of the underlying hepatitis B virus infection and a few were due to non-A, non-B hepatitis superinfection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3141291     DOI: 10.1007/bf01650760

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  19 in total

1.  Etiology of sporadic hepatitis B surface antigen-negative hepatitis.

Authors:  J L Dienstag; A Alaama; J W Mosley; A G Redeker; R H Purcell
Journal:  Ann Intern Med       Date:  1977-07       Impact factor: 25.391

2.  Epidemiology and clinical characteristics of acute hepatitis types A, B, and non-A non-B.

Authors:  L R Mathiesen; P Skinhøj; F Hardt; J O Nielsen; K Sloth; H Zoffmann; A M Møller; D Wong; R H Purcell
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

3.  How often does chronic liver disease follow acute hepatitis B in adults?

Authors:  A Roumeliotou-Karayannis; N Tassopoulos; S C Richardson; P Kalafatas; G Papaevangelou
Journal:  Infection       Date:  1985 Jul-Aug       Impact factor: 3.553

4.  Correlation of age with the status of hepatitis B virus replication and histological changes in chronic type B hepatitis.

Authors:  C H Chu; Y F Liaw; I S Sheen; T J Chen
Journal:  Liver       Date:  1985-06

5.  Non-A, non-B hepatitis in West London.

Authors:  L J Farrow; J S Stewart; H Stern; R E Clifford; H G Smith; A J Zuckerman
Journal:  Lancet       Date:  1981-05-02       Impact factor: 79.321

6.  The etiology of acute viral hepatitis in an endemic area of hepatitis A and B.

Authors:  Y F Liaw; C M Chu; M J Huang; T J Chen; D Y Lin
Journal:  Am J Trop Med Hyg       Date:  1983-11       Impact factor: 2.345

7.  Presence and meaning of anti-HBc IgM as determined by ELISA in patients with acute type B hepatitis and healthy HBsAg carriers.

Authors:  P Kryger; L R Mathiesen; J Aldershville; J O Nielsen
Journal:  Hepatology       Date:  1981 May-Jun       Impact factor: 17.425

8.  Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum.

Authors:  C M Chu; P Karayiannis; M J Fowler; J Monjardino; Y F Liaw; H C Thomas
Journal:  Hepatology       Date:  1985 May-Jun       Impact factor: 17.425

9.  Diagnostic and prognostic significance of the IgM antibody to the hepatitis delta virus.

Authors:  P Farci; J L Gerin; M Aragona; I Lindsey; O Crivelli; A Balestrieri; A Smedile; H C Thomas; M Rizzetto
Journal:  JAMA       Date:  1986-03-21       Impact factor: 56.272

10.  Sex difference in chronic hepatitis B virus infection: an appraisal based on the status of hepatitis B e antigen and antibody.

Authors:  C M Chu; Y F Liaw; I S Sheen; D Y Lin; M J Huang
Journal:  Hepatology       Date:  1983 Nov-Dec       Impact factor: 17.425

View more
  10 in total

1.  Viral superinfection in previously unrecognized chronic carriers of hepatitis B virus with superimposed acute fulminant versus nonfulminant hepatitis.

Authors:  C M Chu; C T Yeh; Y F Liaw
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

2.  Etiology of acute hepatitis superimposed on hepatitis B surface antigen carriage.

Authors:  N C Tassopoulos; P Nikolakakis; P Zorbas; H Stefatou; M Koutelou; A Karanassou; A Tagaris; P Kalafatas
Journal:  Infection       Date:  1989 Mar-Apr       Impact factor: 3.553

Review 3.  Acute exacerbation of chronic hepatitis B: the dilemma of differentiation from acute viral hepatitis B.

Authors:  Pankaj Puri
Journal:  J Clin Exp Hepatol       Date:  2013-10-17

4.  The incidence of fulminant hepatic failure in acute viral hepatitis in Taiwan: increased risk in patients with pre-existing HBsAg carrier state.

Authors:  C M Chu; Y F Liaw
Journal:  Infection       Date:  1990 Jul-Aug       Impact factor: 3.553

5.  Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus.

Authors:  C M Chu; C T Yeh; Y F Liaw
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

6.  Differentiating acute hepatitis B from the first episode of symptomatic exacerbation of chronic hepatitis B.

Authors:  Manoj Kumar; Sanjay Jain; Barjesh Chander Sharma; Shiv Kumar Sarin
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

7.  Acute hepatitis B or exacerbation of chronic hepatitis B-that is the question.

Authors:  Efrat Orenbuch-Harroch; Liran Levy; Eldad Ben-Chetrit
Journal:  World J Gastroenterol       Date:  2008-12-14       Impact factor: 5.742

8.  Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Authors:  S K Sarin; M Kumar; G K Lau; Z Abbas; H L Y Chan; C J Chen; D S Chen; H L Chen; P J Chen; R N Chien; A K Dokmeci; Ed Gane; J L Hou; W Jafri; J Jia; J H Kim; C L Lai; H C Lee; S G Lim; C J Liu; S Locarnini; M Al Mahtab; R Mohamed; M Omata; J Park; T Piratvisuth; B C Sharma; J Sollano; F S Wang; L Wei; M F Yuen; S S Zheng; J H Kao
Journal:  Hepatol Int       Date:  2015-11-13       Impact factor: 6.047

9.  Gender Impacts on the Disease Severity of Overt Acute Hepatitis A: Different from Overt Acute Hepatitis B.

Authors:  Ming-Ling Chang; Yun-Fan Liaw
Journal:  Dig Dis Sci       Date:  2018-10-25       Impact factor: 3.199

10.  The dilemma of differentiating between acute hepatitis B and chronic hepatitis B with acute exacerbation: Is quantitative serology the answer?

Authors:  Sujata Lall; Pragya Agarwala; Guresh Kumar; Manoj Kumar Sharma; Ekta Gupta
Journal:  Clin Mol Hepatol       Date:  2020-04-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.